Cargando…
The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
Fragile X Syndrome (FXS) is the most frequent cause of inherited intellectual disabilities and autism spectrum disorders, characterized by cognitive deficits and autistic behaviors. The silencing of the Fmr1 gene and consequent lack of FMRP protein, is the major contribution to FXS pathophysiology....
Autores principales: | Romagnoli, Alice, Di Marino, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599826/ https://www.ncbi.nlm.nih.gov/pubmed/34803767 http://dx.doi.org/10.3389/fpsyt.2021.754485 |
Ejemplares similares
-
Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome
por: Razak, Khaleel A., et al.
Publicado: (2021) -
Experiences of the Molecular Diagnosis of Fragile X Syndrome in Ecuador
por: Pozo-Palacios, Juan, et al.
Publicado: (2021) -
Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments
por: Verdura, Edgard, et al.
Publicado: (2021) -
Mental Health Challenges, Parenting Stress, and Features of the Couple Relationship in Parents of Children With Fragile X Syndrome
por: Potter, Sarah Nelson, et al.
Publicado: (2022) -
Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial
por: Champigny, Camille, et al.
Publicado: (2022)